VLS-1488

N/A

Report date: 2024/10/08 09:47:48
NME

Base Information

Drug NameVLS-1488
Drug Alias NameVLS-1488
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKinesin-like protein KIF18A inhibitors
TargetsKinesin-like protein KIF18A
Therapy Area/IndicationsSolid tumoursChromosomal InstabilityEndometrial Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVolastra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVolastra Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursChromosomal InstabilityEndometrial Neoplasms +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A